This report contains market size and forecasts of Respiratory Distress Syndrome in Global, including the following market information:
Global Respiratory Distress Syndrome Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Respiratory Distress Syndrome market was valued at 404.6 million in 2020 and is projected to reach US$ 496.7 million by 2027, at a CAGR of 5.3% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Respiratory Distress Syndrome
ALSO READ : http://www.marketwatch.com/story/respiratory-distress-syndrome-mark...
companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Respiratory Distress Syndrome Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Respiratory Distress Syndrome Market Segment Percentages, By Type, 2020 (%)
Poractant Alfa
Beractant
Calfactant
Others
China Respiratory Distress Syndrome Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Respiratory Distress Syndrome Market Segment Percentages, By Application, 2020 (%)
Very Preterm Infants
Moderate to Late Preterm Infants
Others
ALSO READ : http://www.marketwatch.com/story/transformer-insulation-paper-marke...
Global Respiratory Distress Syndrome Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Respiratory Distress Syndrome Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
ALSO READ : http://www.marketwatch.com/story/radar-sensor-market-in-depth-and-p...
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Respiratory Distress Syndrome Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Respiratory Distress Syndrome Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
ALSO READ : http://www.marketwatch.com/story/microfluidics-technology-market-re...
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Respiratory Distress Syndrome Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Respiratory Distress Syndrome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Respiratory Distress Syndrome Overall Market Size
2.1 Global Respiratory Distress Syndrome Market Size: 2021 VS 2027
2.2 Global Respiratory Distress Syndrome Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Respiratory Distress Syndrome Players in Global Market
3.2 Top Global Respiratory Distress Syndrome Companies Ranked by Revenue
3.3 Global Respiratory Distress Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Respiratory Distress Syndrome Companies in Global Market, by Revenue in 2020
3.5 Global Companies Respiratory Distress Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Respiratory Distress Syndrome Players in Global Market
3.6.1 List of Global Tier 1 Respiratory Distress Syndrome Companies
3.6.2 List of Global Tier 2 and Tier 3 Respiratory Distress Syndrome Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Respiratory Distress Syndrome Market Size Markets, 2021 & 2027
4.1.2 Poractant Alfa
4.1.3 Beractant
4.1.4 Calfactant
4.1.5 Others
4.2 By Type - Global Respiratory Distress Syndrome Revenue & Forecasts
4.2.1 By Type - Global Respiratory Distress Syndrome Revenue, 2016-2021
4.2.2 By Type - Global Respiratory Distress Syndrome Revenue, 2022-2027
4.2.3 By Type - Global Respiratory Distress Syndrome Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Respiratory Distress Syndrome Market Size, 2021 & 2027
5.1.2 Very Preterm Infants
5.1.3 Moderate to Late Preterm Infants
5.1.4 Others
5.2 By Application - Global Respiratory Distress Syndrome Revenue & Forecasts
5.2.1 By Application - Global Respiratory Distress Syndrome Revenue, 2016-2021
5.2.2 By Application - Global Respiratory Distress Syndrome Revenue, 2022-2027
5.2.3 By Application - Global Respiratory Distress Syndrome Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Respiratory Distress Syndrome Market Size, 2021 & 2027
6.2 By Region - Global Respiratory Distress Syndrome Revenue & Forecasts
6.2.1 By Region - Global Respiratory Distress Syndrome Revenue, 2016-2021
6.2.2 By Region - Global Respiratory Distress Syndrome Revenue, 2022-2027
6.2.3 By Region - Global Respiratory Distress Syndrome Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Respiratory Distress Syndrome Revenue, 2016-2027
6.3.2 US Respiratory Distress Syndrome Market Size, 2016-2027
6.3.3 Canada Respiratory Distress Syndrome Market Size, 2016-2027
6.3.4 Mexico Respiratory Distress Syndrome Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Respiratory Distress Syndrome Revenue, 2016-2027
6.4.2 Germany Respiratory Distress Syndrome Market Size, 2016-2027
6.4.3 France Respiratory Distress Syndrome Market Size, 2016-2027
6.4.4 U.K. Respiratory Distress Syndrome Market Size, 2016-2027
6.4.5 Italy Respiratory Distress Syndrome Market Size, 2016-2027
6.4.6 Russia Respiratory Distress Syndrome Market Size, 2016-2027
6.4.7 Nordic Countries Respiratory Distress Syndrome Market Size, 2016-2027
6.4.8 Benelux Respiratory Distress Syndrome Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Respiratory Distress Syndrome Revenue, 2016-2027
6.5.2 China Respiratory Distress Syndrome Market Size, 2016-2027
6.5.3 Japan Respiratory Distress Syndrome Market Size, 2016-2027
6.5.4 South Korea Respiratory Distress Syndrome Market Size, 2016-2027
6.5.5 Southeast Asia Respiratory Distress Syndrome Market Size, 2016-2027
6.5.6 India Respiratory Distress Syndrome Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Respiratory Distress Syndrome Revenue, 2016-2027
6.6.2 Brazil Respiratory Distress Syndrome Market Size, 2016-2027
6.6.3 Argentina Respiratory Distress Syndrome Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Respiratory Distress Syndrome Revenue, 2016-2027
6.7.2 Turkey Respiratory Distress Syndrome Market Size, 2016-2027
6.7.3 Israel Respiratory Distress Syndrome Market Size, 2016-2027
6.7.4 Saudi Arabia Respiratory Distress Syndrome Market Size, 2016-2027
6.7.5 UAE Respiratory Distress Syndrome Market Size, 2016-2027
7 Players Profiles
7.1 Chiesi Farmaceutici
7.1.1 Chiesi Farmaceutici Corporate Summary
ALSO READ : http://www.marketwatch.com/story/regional-dark-chocolate-industry-s...
7.1.2 Chiesi Farmaceutici Business Overview
7.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Major Product Offerings
7.1.4 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue in Global (2016-2021)
7.1.5 Chiesi Farmaceutici Key News
7.2 CR-Double Crane
7.2.1 CR-Double Crane Corporate Summary
7.2.2 CR-Double Crane Business Overview
7.2.3 CR-Double Crane Respiratory Distress Syndrome Major Product Offerings
7.2.4 CR-Double Crane Respiratory Distress Syndrome Revenue in Global (2016-2021)
7.2.5 CR-Double Crane Key News
7.3 ONY Biotech
7.3.1 ONY Biotech Corporate Summary
7.3.2 ONY Biotech Business Overview
7.3.3 ONY Biotech Respiratory Distress Syndrome Major Product Offerings
7.3.4 ONY Biotech Respiratory Distress Syndrome Revenue in Global (2016-2021)
7.3.5 ONY Biotech Key News
7.4 AbbVie
7.4.1 AbbVie Corporate Summary
7.4.2 AbbVie Business Overview
7.4.3 AbbVie Respiratory Distress Syndrome Major Product Offerings
7.4.4 AbbVie Respiratory Distress Syndrome Revenue in Global (2016-2021)
7.4.5 AbbVie Key News
7.5 Yuhan Corporation
7.5.1 Yuhan Corporation Corporate Summary
7.5.2 Yuhan Corporation Business Overview
7.5.3 Yuhan Corporation Respiratory Distress Syndrome Major Product Offerings
7.5.4 Yuhan Corporation Respiratory Distress Syndrome Revenue in Global (2016-2021)
7.5.5 Yuhan Corporation Key News
7.6 JW Pharmaceuticals
7.6.1 JW Pharmaceuticals Corporate Summary
7.6.2 JW Pharmaceuticals Business Overview
7.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Major Product Offerings
7.6.4 JW Pharmaceuticals Respiratory Distress Syndrome Revenue in Global (2016-2021)
7.6.5 JW Pharmaceuticals Key News
7.7 Noargen
7.7.1 Noargen Corporate Summary
7.7.2 Noargen Business Overview
7.7.3 Noargen Respiratory Distress Syndrome Major Product Offerings
7.4.4 Noargen Respiratory Distress Syndrome Revenue in Global (2016-2021)
7.7.5 Noargen Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Respiratory Distress Syndrome Market Opportunities & Trends in Global Market
Table 2. Respiratory Distress Syndrome Market Drivers in Global Market
Table 3. Respiratory Distress Syndrome Market Restraints in Global Market
Table 4. Key Players of Respiratory Distress Syndrome in Global Market
Table 5. Top Respiratory Distress Syndrome Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Respiratory Distress Syndrome Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Respiratory Distress Syndrome Revenue Share by Companies, 2016-2021
Table 8. Global Companies Respiratory Distress Syndrome Product Type
Table 9. List of Global Tier 1 Respiratory Distress Syndrome Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Respiratory Distress Syndrome Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Respiratory Distress Syndrome Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Respiratory Distress Syndrome Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Respiratory Distress Syndrome Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Respiratory Distress Syndrome Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Respiratory Distress Syndrome Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Respiratory Distress Syndrome Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Respiratory Distress Syndrome Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Respiratory Distress Syndrome Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Respiratory Distress Syndrome Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Respiratory Distress Syndrome Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Respiratory Distress Syndrome Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Respiratory Distress Syndrome Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Respiratory Distress Syndrome Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Respiratory Distress Syndrome Revenue, (US$, Mn), 2022-2027
Table 30. Chiesi Farmaceutici Corporate Summary
Table 31. Chiesi Farmaceutici Respiratory Distress Syndrome Product Offerings
Table 32. Chiesi Farmaceutici Respiratory Distress Syndrome Revenue (US$, Mn), (2016-2021)
Table 33. CR-Double Crane Corporate Summary
Table 34. CR-Double Crane Respiratory Distress Syndrome Product Offerings
Table 35. CR-Double Crane Respiratory Distress Syndrome Revenue (US$, Mn), (2016-2021)
Table 36. ONY Biotech Corporate Summary
Table 37. ONY Biotech Respiratory Distress Syndrome Product Offerings
Table 38. ONY Biotech Respiratory Distress Syndrome Revenue (US$, Mn), (2016-2021)
Table 39. AbbVie Corporate Summary
Table 40. AbbVie Respiratory Distress Syndrome Product Offerings
Table 41. AbbVie Respiratory Distress Syndrome Revenue (US$, Mn), (2016-2021)
Table 42. Yuhan Corporation Corporate Summary
Table 43. Yuhan Corporation Respiratory Distress Syndrome Product Offerings
Table 44. Yuhan Corporation Respiratory Distress Syndrome Revenue (US$, Mn), (2016-2021)
Table 45. JW Pharmaceuticals Corporate Summary
Table 46. JW Pharmaceuticals Respiratory Distress Syndrome Product Offerings
Table 47. JW Pharmaceuticals Respiratory Distress Syndrome Revenue (US$, Mn), (2016-2021)
Table 48. Noargen Corporate Summary
Table 49. Noargen Respiratory Distress Syndrome Product Offerings
Table 50. Noargen Respiratory Distress Syndrome Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Respiratory Distress Syndrome Segment by Type
Figure 2. Respiratory Distress Syndrome Segment by Application
Figure 3. Global Respiratory Distress Syndrome Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Respiratory Distress Syndrome Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Respiratory Distress Syndrome Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Respiratory Distress Syndrome Revenue in 2020
Figure 8. By Type - Global Respiratory Distress Syndrome Revenue Market Share, 2016-2027
Figure 9. By Application - Global Respiratory Distress Syndrome Revenue Market Share, 2016-2027
Figure 10. By Region - Global Respiratory Distress Syndrome Revenue Market Share, 2016-2027
Figure 11. By Country - North America Respiratory Distress Syndrome Revenue Market Share, 2016-2027
Figure 12. US Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Respiratory Distress Syndrome Revenue Market Share, 2016-2027
Figure 16. Germany Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 17. France Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Respiratory Distress Syndrome Revenue Market Share, 2016-2027
Figure 24. China Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 28. India Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Respiratory Distress Syndrome Revenue Market Share, 2016-2027
Figure 30. Brazil Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Respiratory Distress Syndrome Revenue Market Share, 2016-2027
Figure 33. Turkey Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Respiratory Distress Syndrome Revenue, (US$, Mn), 2016-2027
Figure 37. Chiesi Farmaceutici Respiratory Distress Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. CR-Double Crane Respiratory Distress Syndrome Revenue Year Over Year Growth (US$, Mn) & (2
....continued

CONTACT DETAILS
[email protected]
+44 203 500 2763
+1 62 825 80070
971 0503084105